{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:15:14Z","timestamp":1789092914032,"version":"build-2803163510"},"reference-count":38,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007761","name":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Direct oral anticoagulants (DOAC) were developed as an alternative to vitamin K antagonists in the treatment of NVAF. Statins are frequently prescribed drugs for the prevention of atherosclerotic cardiovascular disease. A potential interaction between DOACs and statins has been described, suggesting that their concomitant use may increase the risk of major bleeding (MB).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To estimate the risk of MB associated with concomitant use of DOACs and statins to assess potential safety issues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A case\u2013control study nested in a cohort of new users of DOACs was performed in BIFAP. Cases were defined as MB events and matched to four controls by risk\u2010set sampling. Treatment episodes were built to define the participants' exposure according to their use at index date as current, recent, past, or no use. Exposure was also assessed in relation to its continuity and duration. Variables were created based on the concomitant use of DOACs and statins to study the interaction, using conditional logistic regression to estimate the risk of MB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>aOR (95% CI) for current use of DOAC or statin use were 1.35 (0.96\u20131.9) and 0.72 (0.59\u20130.88). aOR for their concomitant use was 1.31 (0.83\u20132.07) compared to nonuse of either of them. DOAC continuous use (1.27; 0.8\u20132.03) and long\u2010term (1.11; 0.67\u20131.81) treatment was associated with smaller risks than noncontinuous (1.40; 0.85\u20132.32) and short\u2010term treatment (1.43; 0.94\u20132.45). Analyses by individual DOACs and statins showed similar results except for edoxaban, which had low numbers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There was no evidence to suggest an interaction between DOACs and statins and the risk of MB. Regular use of DOACs is important to minimize their impact on MB onset.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pds.70245","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T13:51:11Z","timestamp":1761400271000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association Between Statins Use and Major Bleeding in Patients Using Direct Oral Anticoagulants for Atrial Fibrillation"],"prefix":"10.1002","volume":"34","author":[{"given":"A.","family":"de Burgos\u2010Gonz\u00e1lez","sequence":"first","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacovigilance Spanish Agency for Medicines and Medical Devices (AEMPS)  Madrid Spain"},{"name":"Department of Public Health and Maternal Child Health, Faculty of Medicine Complutense University of Madrid  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7051-0730","authenticated-orcid":false,"given":"L.","family":"Cea\u2010Soriano","sequence":"additional","affiliation":[{"name":"Department of Public Health and Maternal Child Health, Faculty of Medicine Complutense University of Madrid  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Huerta\u2010\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacovigilance Spanish Agency for Medicines and Medical Devices (AEMPS)  Madrid Spain"},{"name":"Department of Public Health and Maternal Child Health, Faculty of Medicine Complutense University of Madrid  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"issue":"4","key":"e_1_2_11_2_1","first-page":"S67","article-title":"Exploring Indications for the Use of Direct Oral Anticoagulants and the Associated Risks of Major Bleeding","volume":"23","author":"Milling T. J.","year":"2017","journal-title":"American Journal of Managed Care"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euw295"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw058"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2018.03.009"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aprim.2016.11.015"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.60103\/phc.v26.e836"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14071"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14227"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4870350"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000625"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018\u2010200730100\u201000009"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265\u2010020\u201001328\u20106"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181\u2010011\u20100178\u2010y"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061120"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160303"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13077"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5006"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538\u20107836.2005.01204.x"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5357"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(85)90039-6"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113439"},{"key":"e_1_2_11_23_1","volume-title":"Modern Epidemiology","author":"Lash T. L.","year":"2020"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40256\u2010013\u20100029\u20100"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/00273171.2011.568786"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.5398"},{"key":"e_1_2_11_27_1","unstructured":"Pharmacovigilance Risk Assessment Committee (PRAC) \u201cMinutes of the Meeting on 6\u20139 February 2017. Chair: June Raine\u2014Vice\u2010Chair: Almath Spooner \u201d(2017) https:\/\/www.ema.europa.eu\/en\/documents\/minutes\/minutes\u2010prac\u2010meeting\u20106\u20109\u2010february\u20102017_en.pdf."},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1055\/s\u20100039\u20101695734"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2024.0349"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.13883"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.969259"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03256595"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16030364"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen\u20102024\u2010085401"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH16\u201010\u20100757"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010022\u201007316\u2010y"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14450"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14764"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40278\u2010023\u201050241\u2010x"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.70245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T08:54:14Z","timestamp":1763715254000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.70245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1002\/pds.70245"],"URL":"https:\/\/doi.org\/10.1002\/pds.70245","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,25]]},"assertion":[{"value":"2025-04-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70245"}}